liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Making HPV Vaccines Efficient: Cost-Effectiveness Analysis and the Economic Assemblage of Healthcare in Colombia
Linköpings universitet, Institutionen för tema, Tema teknik och social förändring. Linköpings universitet, Filosofiska fakulteten.
2018 (engelsk)Inngår i: Science & Technology Studies, E-ISSN 2243-4690, Vol. 31, nr 2Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Cost-effectiveness analysis is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and individuals behaviour. This article analyses the role of cost-effectiveness analysis as a device to produce value in the introduction of human papillomavirus vaccines to Colombia. In different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and exclusions that such technology entails. Cost-effectiveness justified the definition of girls as the population target and the exclusion of boys from the risks and benefits of this technology. Cost-effectiveness analysis has been a key instrument in the sexualising and desexualising of cervical cancer and human papillomavirus vaccines through the rationalisation of economic benefits.

sted, utgiver, år, opplag, sider
Tampere, Finland: Finnish Society for Science and Technology Studies , 2018. Vol. 31, nr 2
Emneord [en]
quantification; HPV vaccines; global health
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-163985DOI: 10.23987/sts.55582ISI: 000432143300001OAI: oai:DiVA.org:liu-163985DiVA, id: diva2:1412297
Merknad

Funding Agencies|European Research CouncilEuropean Research Council (ERC) [263657]

Tilgjengelig fra: 2020-03-05 Laget: 2020-03-05 Sist oppdatert: 2020-03-27bibliografisk kontrollert

Open Access i DiVA

fulltext(156 kB)12 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 156 kBChecksum SHA-512
b6169e4e7c33d6b13087c9b052addfd85efb5cd8558a3e05fcb7a1bccdd2c7d2880f7cd05543115f24ad8c38e1ef8b212f8a6022e4c1b575e8a16b607f761953
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekst

Søk i DiVA

Av forfatter/redaktør
Maldonado Castaneda, Oscar
Av organisasjonen
I samme tidsskrift
Science & Technology Studies

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 12 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 22 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf